1,940
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

A novel SigB(Q225P) mutation in Staphylococcus aureus retains virulence but promotes biofilm formation

, , , , , , , , , , , , , , & show all
Pages 1-12 | Received 17 Dec 2017, Accepted 19 Mar 2018, Published online: 25 Apr 2018

Abstract

Staphylococcus aureus is an important pathogen that produces abundant virulence factors, which cause various diseases that burden human health worldwide. The stress response regulon called sigma factor B (SigB) is a well-characterized global regulator that is involved in the regulation of S. aureus virulence, pigmentation, and biofilm formation. However, the regulatory network upon SigB in S. aureus is incompletely described. Here, we identified a novel substitution mutation, SigB(Q225P), which contributed the nonpigmented phenotype of S. aureus. The S. aureus mutant carrying SigB(Q225P) substitution lacks staphyloxanthin, a key virulence factor in protecting bacteria from host-oxidant killing, but retains bacterial pathogenicity with pleiotropic alterations in virulence factors, resulting in similar lethality and abscess formation ability in animal models. We also reported the SigB(Q225P) promotion of biofilm formation in S. aureus. Real-time quantitative polymerase chain reaction (RT-qPCR) revealed that the expression of nuc gene, which encodes thermonuclease, was significantly downregulated, resulting in accumulation of eDNA in the biofilm of SigB(Q225P) mutant strain. LacZ reporter assay showed that SigB(Q225P) influenced the activity of nuc promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and Bio-layer interferometry (BLI) assay revealed that both SigB and SigB(Q225P) proteins could directly bind to nuc gene promoter; however, the binding activity decreased for SigB(Q225P). Our data renewed the understanding of the relationship between S. aureus golden pigment and its virulence and suggested that a single substitution mutation in SigB might enhance the biofilm formation of S. aureus by directly downregulating nuc expression.

These authors contributed equally: Hui Liu, Weilong Shang, Zhen Hu.

Introduction

Staphylococcus aureus is a notorious pathogen capable of causing various diseases, ranging from acute skin and soft tissue infections to chronic or persistent endocarditis, osteomyelitis, and implant infectionsCitation1Citation3. S. aureus infections have brought great economic and social burdens worldwide. In China, according to China Antimicrobial Resistance Surveillance System (http://www.carss.cn/), S. aureus ranked the first among Gram-positive pathogenic bacteria. In the United States, a single community-associated methicillin-resistant S. aureus imposes an annual burden of about $2 billion on third-party payers and $10 billion on societyCitation4. S. aureus bacteria frequently act as versatile members that develop surface-attached community-designed biofilms to protect themselves from antibiotics treatment, host-immune killing, and other unfavorable environmentsCitation5Citation8 and to activate the production of virulence factors contributing to bacterial colonization, persistence, and spreadingCitation9, Citation10. Nevertheless, the regulatory network underlying biofilm formation of S. aureus is extremely complicated but poorly understood.

S. aureus biofilms consist of complex extracellular matrixes (ECMs), including polysaccharide intercellular adhesion (PIA), proteins, and extracellular DNA (eDNA)Citation11. Alternative sigma factor B (SigB), which majorly modulates the stress responses of several Gram-positive bacteriaCitation12, plays essential roles in regulating biofilm formation, virulence expression, and pigment synthesis of S. aureusCitation13Citation17. The biosynthesis of staphyloxanthin, a key virulence factor for protecting S. aureus from host-oxidant killing in vivoCitation18, depends on the alternative SigBCitation19. The increased expression of SigB is always accompanied by enhanced biofilm formationCitation20, whereas sigB gene-deleted mutant is unable to create a biofilm in both S. aureusCitation21 and S. epidermidisCitation22. S. aureus variants carrying certain substitution mutation in SigB (such as L242P) or truncated SigB do not produce pigment nor form biofilmCitation23.

Theoretically, one substitution mutation in a certain molecule has three modes of influence (increase, decrease, or no change) on certain phenotype as compared with the wild-type molecule. However, in transcriptional regulators such as SigB, mutations in the DNA-binding domain tend to attenuate the protein’s function. In this study, we obtained a nonpigmented variant (XQW) from Luria-Bertain (LB) agar plates cultivated in the fifth passage of S. aureus XQ, a highly virulent strain isolated from the pus of a 17-year-old adolescentCitation24. Genome sequencing and comparison revealed that XQW carried a novel SigB mutation, SigB(Q225P). Allelic replacement experiments in S. aureus Newman indicated that SigB(Q225P) mutation was responsible for the nonpigmented phenotype of S. aureus. However, the lack of staphyloxanthin did not affect bacterial virulence in animal killing and skin abscess formation in mouse models. SigB(Q225P) enhanced the biofilm formation of S. aureus. Further study showed that the increased biofilm of XQW was associated with the decreased nuc (encoding thermonuclease) expression of bacteria, resulting in accumulation of eDNA in the biofilm ECMs. LacZ reporter assay, electrophoretic mobility shift assay (EMSA), and Bio-layer interferometry (BLI) assay showed that SigB(Q225P) mutation weakened the direct interaction between SigB protein and nuc gene promoter, which consequently reduced nuc expression and enhanced biofilm formation. Our study provided initial evidence that a substitution mutation of SigB(Q225P) could increase the biofilm formation of S. aureus. The underlying mechanism has also been elucidated.

Results

SigB(Q225P) mutation contributes to the nonpigmented phenotypes of S. aureus

The genetic plasticity enables S. aureus, a versatile microorganism, to adapt to the environmentCitation23. We previously isolated a highly virulent ST121/agr-IV methicillin-susceptible S. aureus (MSSA, termed XQ strain)Citation24. After five passages of XQ in laboratory with LB medium, about 2% colonies on the LB agar plate exhibited white phenotypes (Fig. ). One of the colorless colonies was then inoculated into tryptic soy broth (TSB), and its white phenotype was stable and named XQW strain (Fig. ).

Fig. 1 Nonpigmented phenotypes of S. aureus XQW and the SigB(Q225P) mutation.

a XQ strain was cultured with LB medium, and the white colonies were observed on an LB plate. The nonpigmented phenotype was stable in the common TSB medium and was termed XQW strain as indicated. b Genome comparison revealed the SigB(Q225P) mutation in XQW. XQ contained the wild-type sigB gene, located approximately at 7 o’clock of its circular genome, whereas XQW contained a missense mutation in sigB(A674C), corresponding to a Q225P substitution in SigB factor, which was further confirmed by PCR amplification and DNA sequencing

Fig. 1 Nonpigmented phenotypes of S. aureus XQW and the SigB(Q225P) mutation.a XQ strain was cultured with LB medium, and the white colonies were observed on an LB plate. The nonpigmented phenotype was stable in the common TSB medium and was termed XQW strain as indicated. b Genome comparison revealed the SigB(Q225P) mutation in XQW. XQ contained the wild-type sigB gene, located approximately at 7 o’clock of its circular genome, whereas XQW contained a missense mutation in sigB(A674C), corresponding to a Q225P substitution in SigB factor, which was further confirmed by PCR amplification and DNA sequencing

The biosynthesis of golden carotenoid pigment (staphyloxanthin) in S. aureus is controlled by the crtOPQMN operon. Many other regulators, such as SigB, IspA, CitZ, CitB, and CcpE, and small RNA SsrA, influence the production of S. aureus staphyloxanthinCitation13, Citation18. Genome sequencing of XQ (GenBank accession number: CP013137.1) and XQW was conducted to identify the gene responsible for the white phenotype of XQW. Genome comparison revealed 527 single-nucleotide polymorphisms (SNPs) in XQW genome; 392 of which were involved in 161 genes, which altered the corresponding amino acids (Supplementary Table S1). XQW contained a missense mutation in sigB(A674C), which encoded glutamine/proline substitution Q225P (Fig. ). This mutation was located in the putative DNA-binding domain of SigB that spans residues of 208–247;Citation25 this mutated gene may be responsible for the white phenotype of XQW.

Due to the difficulty of genetic manipulation of the clinical isolate XQ, we introduced the SigB(Q225P) mutation into the strain Newman, a well-characterized MSSA strain, and tested the relationship between the mutation and the white colony phenotype. As expected, Newman-SigB(Q225P) and SigB mutant strain Newman-ΔSigB revealed nonpigmented phenotypes similar to those of XQW (Fig. ). The production of carotenoids was also determined, and the results indicated that Newman-SigB(Q225P) synthesized a decreased level of carotenoids as compared with wild-type Newman (Fig. ). These data suggested that the SigB(Q225P) mutation in S. aureus contributed to the nonpigmented phenotypes of S. aureus variants.

Fig. 2 S. aureus Newman with SigB(Q225P) mutation exhibited the nonpigmented phenotype.

a Colonies of Newman, Newman-ΔSigB, and Newman-SigB(Q225P) on TSB plates. b Cell pellets of Newman, Newman-ΔSigB, and Newman-SigB(Q225P) from TSB cultures. c Carotenoids produced by Newman, Newman-ΔSigB, and Newman-SigB(Q225P) were extracted, and the OD462 value was determined (n = 3). ***P< 0.001

Fig. 2 S. aureus Newman with SigB(Q225P) mutation exhibited the nonpigmented phenotype.a Colonies of Newman, Newman-ΔSigB, and Newman-SigB(Q225P) on TSB plates. b Cell pellets of Newman, Newman-ΔSigB, and Newman-SigB(Q225P) from TSB cultures. c Carotenoids produced by Newman, Newman-ΔSigB, and Newman-SigB(Q225P) were extracted, and the OD462 value was determined (n = 3). ***P < 0.001

SigB(Q225P) mutation retains the virulence of S. aureus

Staphyloxanthin is an important virulence factor to protect S. aureus from host-oxidant killingCitation26. Inhibitors targeting staphyloxanthin biosynthesis impair S. aureus virulenceCitation18, Citation27. The expression levels of several major virulence factors were detected by RT-qPCR to investigate the influence of SigB(Q225P) mutation on the virulence of XQW (Fig. ). The results revealed that RNAIII, which controls the expression of many virulence factorsCitation28, was significantly upregulated in XQW as compared with that in XQ. The genes encoding γ-hemolysin (hlg), staphylococcal enterotoxin B (seb), and Pantone-Valentine leucocidin (lukF) were also upregulated, whereas those encoding α-hemolysin (hla) and lipase (lipA) were significantly downregulated in XQW. No alteration in the expression of gene encoding V8 serine protease (sspA) was observed between XQW and XQ.

Fig. 3 Expression levels of virulence genes (RNAIII, hlg, seb, lukF, hla, lipA, and sspA) in XQ and XQW determined by RT-qPCR.

Expression of each gene of interest in XQ strain was normalized to the 16S RNA gene expression and adjusted to 1.0, and its relative expression in XQW strain was indicated. *P< 0.05, **P< 0.01, ***P< 0.001, and ns represents no significance, n = 3

Fig. 3 Expression levels of virulence genes (RNAIII, hlg, seb, lukF, hla, lipA, and sspA) in XQ and XQW determined by RT-qPCR.Expression of each gene of interest in XQ strain was normalized to the 16S RNA gene expression and adjusted to 1.0, and its relative expression in XQW strain was indicated. *P < 0.05, **P < 0.01, ***P < 0.001, and ns represents no significance, n = 3

Although the alteration of virulence factor expression in XQW was pleiotropic (Fig. ), the overall lethality was similar in mice (n= 10) challenged by tail vein injection with 4 × 107 CFU of XQ or XQW bacteria (Fig. ). The bacterial loads were also not significantly changed in the kidney (Fig. ), liver (Supplementary Figure S1A), and spleen (Supplementary Figure S1B) of infected mice. As a highly virulent invasive clinical isolate, XQ and XQW caused similar abscess in a skin-infected model (Fig. ). Moreover, the pathogenicity of Newman and Newman-SigB(Q225P) was also similarly evaluated by survival rate, bacterial loads, and abscess formation abilities (Supplementary Figure S2). These data indicated that the SigB(Q225P) mutation in S. aureus impaired the staphyloxanthin production but retained bacterial virulence.

Fig. 4 Virulence of XQ and XQW in mouse models.

a Survival analysis. Mice were injected through tail vein with 4 × 107 CFU of XQ, XQW, or PBS, and the survival rates were calculated. Number of mice used: n= 10. b Bacterial loads. Mice were injected through tail vein with 1 × 107 CFU of XQ or XQW; bacterial load in the kidney tissue was counted four days post-injection. c Skin abscess formation. The hairs on the back of the mice were removed using 6% Na2S, then mice were respectively injected with XQ and XQW on each side. The skin abscesses were photographed 10 days after injection. d Diameter of abscess area was measured and represented as mean ± SD (n ≥ 3); ns represents no significance

Fig. 4 Virulence of XQ and XQW in mouse models.a Survival analysis. Mice were injected through tail vein with 4 × 107 CFU of XQ, XQW, or PBS, and the survival rates were calculated. Number of mice used: n = 10. b Bacterial loads. Mice were injected through tail vein with 1 × 107 CFU of XQ or XQW; bacterial load in the kidney tissue was counted four days post-injection. c Skin abscess formation. The hairs on the back of the mice were removed using 6% Na2S, then mice were respectively injected with XQ and XQW on each side. The skin abscesses were photographed 10 days after injection. d Diameter of abscess area was measured and represented as mean ± SD (n ≥ 3); ns represents no significance

SigB(Q225P) mutation promotes the biofilm formation of S. aureus

The growth rate of XQW was slightly faster than that of XQ (Supplementary Figure S3A); while Newman-SigB(Q225P) showed similar growth rate to that of the wild-type Newman (Supplementary Figure S3B). Interestingly, XQW exhibited flocculent growth in the LB medium, whereas XQ maintained turbid growth (Fig. ). SigB positively regulated the biofilm formation in S. aureus; SigB mutant (ΔSigB) or S. aureus with a substitution mutation in SigB (such as L242P) was unable to develop a biofilmCitation21, Citation23. According to the flocculent growth phenomenon, we speculated that SigB(Q225P) mutation in XQW promoted its biofilm formation. Crystal violet staining method was used to detect the biofilm formation of XQ and XQW in a 24-well plate and thus confirm this conjecture. The results revealed that XQW had stronger biofilm formation ability than XQ (Fig. ). Confocal scanning laser microscopy also showed that XQW produced thicker and more compact biofilm than XQ (Fig. ), indicating that the biofilm formation in XQW was significantly enhanced.

Fig. 5 Detection of biofilm formation in S. aureus XQ and XQW.

a XQW strain exhibited flocculent growth in LB medium. b Detection of biofilm formation with crystal violet staining method. The OD492 values were represented as mean ± SD (n = 3). **P< 0.01. c Biofilms derived from XQ and XQW strains were observed under a confocal scanning laser microscope. The polysaccharides in biofilm were stained green, and the bacteria were stained red. XQW produced thicker and more compact biofilm than XQ

Fig. 5 Detection of biofilm formation in S. aureus XQ and XQW.a XQW strain exhibited flocculent growth in LB medium. b Detection of biofilm formation with crystal violet staining method. The OD492 values were represented as mean ± SD (n = 3). **P < 0.01. c Biofilms derived from XQ and XQW strains were observed under a confocal scanning laser microscope. The polysaccharides in biofilm were stained green, and the bacteria were stained red. XQW produced thicker and more compact biofilm than XQ

By genetically manipulating S. aureus strain Newman and its derivatives, crystal violet staining revealed that the biofilm formation of Newman-SigB(Q225P) was significantly increased compared with that of Newman (Fig. ). This phenomenon was further confirmed by observing biofilms under a confocal microscope (Fig. ). However, the biofilm formation of Newman-ΔSigB was decreased when compared with that of Newman. The supplement of the wild-type SigB to Newman-ΔSigB (Newman-ΔSigB/SigB) elevated its biofilm formation similarly to wild-type Newman. Newman-ΔSigB/SigB increased its biofilm formation compared with Newman-ΔSigB carrying an empty plasmid (Newman-ΔSigB/pLI50). Moreover, supplement of the SigB(Q225P) to Newman-ΔSigB (Newman-ΔSigB/SigB(Q225P)) even enhanced the biofilm formation compared with both Newman-ΔSigB and Newman-ΔSigB/pLI50 (Fig. ). These data indicated that SigB(Q225P) is the key mutation for promoting biofilm formation in S. aureus.

Fig. 6 Detection of biofilm formation in S. aureus strain Newman and its derivatives.

a Crystal violet staining method. Biofilms derived from Newman and its derivatives were stained with crystal violet, and the OD492 was detected (n= 3). *P< 0.05, **P< 0.01, ***P< 0.001, and ns represents no significance. b Observation of biofilm under a confocal microscope. Biofilms produced by Newman and Newman-SigB(Q225P) were indicated. The polysaccharides in biofilm were stained green, and the bacteria were stained red. Newman-SigB(Q225P) exhibited stronger biofilm developing ability than Newman

Fig. 6 Detection of biofilm formation in S. aureus strain Newman and its derivatives.a Crystal violet staining method. Biofilms derived from Newman and its derivatives were stained with crystal violet, and the OD492 was detected (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, and ns represents no significance. b Observation of biofilm under a confocal microscope. Biofilms produced by Newman and Newman-SigB(Q225P) were indicated. The polysaccharides in biofilm were stained green, and the bacteria were stained red. Newman-SigB(Q225P) exhibited stronger biofilm developing ability than Newman

SigB(Q225P) promotes biofilm formation of S. aureus by direct downregulation of nuc expression

One of the hallmark events in biofilm formation is the production of slime PIA controlled by the icaADBC operonCitation29. However, S. aureus can develop an alternative ica-independent biofilmCitation30, where the surface proteins, such as FnBPA/B, ClfA/B, Bap, SPA, and SasGCitation17, Citation31, and extracellular DNA (eDNA) play important rolesCitation21, Citation30. The genes involved in the production of PIA, surface proteins, or eDNA were selected and tested by RT-qPCR to explore the mechanisms by which SigB(Q225P) promotes the biofilm formation in S. aureus. As shown in Fig. , the nuc gene expression was significantly reduced in XQW as compared with that in XQ. The decreased nuc expression could also be observed in Newman-SigB(Q225P) as compared with Newman wild-type strain (Supplementary Figure S4). However, nuc expression was significantly upregulated in the sigB-deleted mutant Newman-ΔSigB, which is in accordance with those of a previous studyCitation21.

Fig. 7 SigB(Q225P) mutation promotes biofilm formation of S. aureus via direct downregulation of nuc expression.

a RT-qPCR detection of the expression level of nuc, fnbA, fnbB, clfA, and icaA genes in XQ and XQW. Only the nuc expression was reduced in XQW strain. **P< 0.01. b eDNA was extracted and determined. XQW biofilms contained more eDNA than XQ. *P< 0.05. c DNase I treatment experiment. The biofilm formation in XQW was significantly reduced after co-incubation with DNase I compared with Tris buffer (20 mM, pH 7.5), whereas biofilm formation in XQ was not changed. *P< 0.05. d β-galactosidase assay. The pOS1-nuc promoter-LacZ reporter plasmid was transformed into Newman and Newman-SigB(Q225P), respectively. The LacZ activity was detected and represented as mean ± SD (n = 3). ***P< 0.001. e EMSA. Interaction between nuc gene promoter and SigB or SigB(Q225P) proteins was detected. The amount of free DNA probes and the shift bands were arrow-indicated. f Evaluation of gray value of the free probe in each lane using ImageJ software. The value of free probe in first lane (0 μg protein) was adjusted to 1.0, and the relative gray values in other lanes were calculated and indicated

Fig. 7 SigB(Q225P) mutation promotes biofilm formation of S. aureus via direct downregulation of nuc expression.a RT-qPCR detection of the expression level of nuc, fnbA, fnbB, clfA, and icaA genes in XQ and XQW. Only the nuc expression was reduced in XQW strain. **P < 0.01. b eDNA was extracted and determined. XQW biofilms contained more eDNA than XQ. *P < 0.05. c DNase I treatment experiment. The biofilm formation in XQW was significantly reduced after co-incubation with DNase I compared with Tris buffer (20 mM, pH 7.5), whereas biofilm formation in XQ was not changed. *P < 0.05. d β-galactosidase assay. The pOS1-nuc promoter-LacZ reporter plasmid was transformed into Newman and Newman-SigB(Q225P), respectively. The LacZ activity was detected and represented as mean ± SD (n = 3). ***P < 0.001. e EMSA. Interaction between nuc gene promoter and SigB or SigB(Q225P) proteins was detected. The amount of free DNA probes and the shift bands were arrow-indicated. f Evaluation of gray value of the free probe in each lane using ImageJ software. The value of free probe in first lane (0 μg protein) was adjusted to 1.0, and the relative gray values in other lanes were calculated and indicated

The thermonuclease encoded by nuc gene negatively regulates eDNA in S. aureus biofilmCitation32. The reduced expression of nuc in XQW would lead to massive accumulation of eDNA in its biofilm development. The amount of eDNA in the biofilm was extracted and determined as described to confirm this hypothesisCitation33. The results showed higher eDNA amount from XQW-derived biofilms than from XQ biofilms (Fig.  and Supplementary Figure S5A). In addition, when DNase I was added into the culture to compensate the decreased expression of thermonuclease, XQW-produced biofilm was significantly decreased, whereas biofilm formation of XQ was not affected (Fig.  and Supplementary Figure S5B). Our data suggested that the decreased nuc expression results in the accumulation of eDNA and may be associated with the enhanced biofilm formation in XQW.

In S. aureus strain COL, SigB deletion led the upregulation of thermonuclease precursorCitation34. A nuc promoter-controlled LacZ reporter plasmid was constructed and transformed into Newman and Newman-SigB(Q225P) strains to test the effect of SigB(Q225P) mutation on the nuc expression. LacZ assay revealed that the activity of nuc promoter in Newman-SigB(Q225P) was only 35.4% of that in the wild-type Newman (Fig. ), indicating that SigB(Q225P) mutation could decrease the expression of nuc gene. We prepared the recombinant SigB and SigB(Q225P) proteins (Supplementary Figure S6A), then used EMSA to determine whether SigB(Q225P) could directly regulate nuc gene or not. The results showed that both recombinant SigB and SigB(Q225P) proteins could bind to nuc gene promoter in a dose-dependent manner (Fig. ) but not to an irrelevant DNA fragment (Supplementary Figure S6B). Moreover, SigB(Q225P) protein exhibited decreased binding ability compared with the wild-type SigB (Fig. ). The band of free probe nearly disappeared when the amount of SigB protein was increased to 12 μg (Fig. , top panel), whereas 18 μg of SigB(Q225P) could not completely exhaust the free probe (Fig. , bottom panel). A BLI assay was also performed to quantitatively detect the DNA binding ability of SigB and SigB(Q225P) proteins. As shown in Fig. , 500 nM recombinant SigB could bind well to the nuc promotor DNA coated biosensor, whereas the same amount of bovine serum albumin (BSA, negative control) could not (Fig. ). SigB showed stronger nuc promotor binding ability (ka = 1.48 × 104, kd = 1.67 × 10−3, KD = 1.13 × 10−7) than SigB(Q225P) (ka  = 5.63 × 103, kd = 1.54 × 10−3, KD = 2.73 × 10−7). These data indicated that SigB(Q225P) promoted biofilm formation in S. aureus by directly downregulating nuc expression, which results in eDNA accumulation.

Fig. 8 The binding sensorgrams (nM) for nuc promotor-SigB or SigB(Q225P) interaction using single cycle kinetic assay format.

a The specificity of the system. BSA served as negative control. b SigB and SigB(Q225P) proteins interacted with nuc promotor in a dose-dependent manner

Fig. 8 The binding sensorgrams (nM) for nuc promotor-SigB or SigB(Q225P) interaction using single cycle kinetic assay format.a The specificity of the system. BSA served as negative control. b SigB and SigB(Q225P) proteins interacted with nuc promotor in a dose-dependent manner

Discussion

Bacterial biofilms are finely organized structures, in which bacteria only constitute ~15% of biofilm volume and are also embedded in ECMsCitation17. The production of ECMs depends on media composition and functional alterations of regulatory factors controlling biofilm formationCitation17, Citation35. Although ECMs of S. aureus biofilms are mainly constituted by PIA, proteins, and eDNA, the regulatory network involved in biofilm formation is complicated. Extracellular proteases (Aur, SpL, SspA, and SspB)Citation20, Citation36Citation38, thermonuclease (Nuc)Citation32, Citation39, autolysins (LytM, LytN, and AtlA)Citation35, toxins (PSMα, PSMβ, and δ-hemolysin)Citation40, holin/antiholin molecules (CidA and LrgAB)Citation33, two-component systems (Agr, WalKR, LytSR, SaeRS, ArlRS, and SrrAB)Citation17, Citation41Citation44, global regulators (SigB, SarA, MgrA, and Rot)Citation16, Citation23, Citation29, Citation30, Citation34, Citation45, Citation46, and non-coding RNAs (msaABCR)Citation35 directly and/or indirectly regulate S. aureus biofilm formation. The alternative SigB is an essential regulator of S. aureus biofilm formation; deletion of sigB deprives biofilm formation in S. aureusCitation20, Citation21. Savage et alCitation23. reported that a single substitution mutation in SigB, L242P, failed to form a biofilm in S. aureus. However, in the present study, we identified a SigB(Q225P) mutation that could unexpectedly promote biofilm formation of S. aureus, at least in strain backgrounds of XQ and Newman. In S. aureus strain COL, Pane-Farre et alCitation34. found that 13 genes are negatively regulated by SigB under alkaline stress conditions, including nuc that encodes thermonuclease precursor. However, our screen with RT-qPCR revealed that nuc was downregulated in XQW (Fig. ) and Newman-SigB(Q225P) (Supplementary Figure S4). LacZ reporter assay showed that SigB(Q225P) reduced nuc expression (Fig. ), and EMSA and BLI revealed that SigB binded to the nuc promoter directly, and the Q225P mutation lowered the DNA binding of SigB(Q225P) to the nuc promoter (Fig. e,f and ). S. aureus SigB is known to be a negative regulator of the nuc expressionCitation47, and the lower DNA binding of SigB(Q225P) downregulation of the nuc expression is puzzling. We speculate that SigB(Q225P) mutation may also downregulate SigB-controlled downstream regulatory factors, such as SpoVG, which can significantly promote the nuc expression by counteracting the repressing effect of SigBCitation47. Therefore, the upregulation of the nuc expression by SigB(Q225P) mutation is presumably over-compensated by the lower level of SpoVG-related downregulation of the nuc expression. As a result, a phenotype of SigB(Q225P)-associated downregulation of nuc expression was observed in this study. However, SigB(Q225P) downregulates SpoVG and the later fine-tunes the nuc expression need further investigation.

The first characteristic in identifying XQW is its nonpigmented phenotype on the LB plate. As an important virulence factor, staphyloxanthin can impair neutrophil killing and protect bacteria against host innate immune systemCitation26, Citation27. Inhibiting the production of staphyloxanthin by small-molecule could attenuate S. aureus virulenceCitation18. We found that the nonpigmented XQW, which carries SigB(Q225P) mutation, retained its virulence similarly to its wild-type XQ in the overall mouse lethality, organ colonization, and skin abscess formation (Fig. ). The virulence between isogenic Newman and Newman-SigB(Q225P) was not statistically different either (Supplementary Figure S2). This phenomenon might be reasonable because the virulence of a certain bacterial strain is the aggregate performance of its virulence factor profiles. Given the pathogenic role of a certain virulence factor, such as staphyloxanthinCitation26, Citation48, the presence and absence of the factor might significantly influence the pathogenicity of the bacterial strain; however, when testing the pathogenic role of a regulator, especially the global regulator (such as SigB or SarA), a single substitution mutation of the regulator might not affect the overall pathogenicity due to the complicated alteration of virulence factor profiles. In the present study, we observed the pleiotropic changes of virulence factors in XQW that carried SigB(Q225P) mutation; the results indicated upregulation in RNAIII, seb, hlg, and lukF expression levels, downregulation in hla and lipA expression levels, and no changes in sspA (Fig. ). The upregulation of RNAIII expression in sigB deleted strain was also reported in a previous study, where the S. aureus strain RN2482 was usedCitation49. The Q225P mutation located in the region 4 domain (residues 208–247) of SigBCitation23, which is in charge the promoter-binding activity, and the virulence factor profiles could be site- and strain-specific due to SigB(Q225P) mutation. S. aureus produces many virulence factors involved in the pathogenicity of a certain strain, and its expression profile of virulence factors could be important in deciding the infectious outcome.

In conclusion, SigB is well established as an important transcriptional regulator in S. aureus to overcome stress conditions. Studies on the effects of substitution mutation on the SigB function were limited. We identified a SigB(Q225P) mutation that contributes to the nonpigmented phenotype of S. aureus. Although this mutation impairs staphyloxanthin production, S. aureus carrying SigB(Q225P) retains its pathogenicity with pleiotropic alterations in the virulence factors, at least in the strain background of XQ and Newman. Moreover, we revealed that the SigB(Q225P) mutation promotes the biofilm formation of S. aureus mainly through the direct downregulation of nuc expression. Our data indicated the important role of eDNA in the S. aureus biofilm formation and an exact pathway (SigB-Nuc-eDNA) controlling the amount of eDNA in ECMs of S. aureus biofilm.

Materials and methods

Bacterial strains, plasmids, and animals

S. aureus strain XQ was isolated from a patient with sepsis from our affiliated hospitalCitation24. The corresponding mutant XQW strain was obtained in the laboratory by serial passages of XQ in LB medium and the fifth passage plating of culture on an agar plate. S. aureus Newman was kindly provided by Professor Yu Lu (Jilin University, China). Escherichia coli DH5α was kept in our laboratory and used for plasmid construction.

Plasmids pBT2 and pLI50, which were used for gene mutation and complementation, respectively, were kindly provided by Professor Baolin Sun (University of Science and Technology of China, China), pET22b for protein preparation and pOS1-LacZ for gene promoter activity detection were kept in our laboratory.

Female 6–8 weeks old BALB/c mice were purchased from our University Animal Center. All animal experiments were approved by the local ethics board at the Third Military Medical University. Guidelines were established by Microbial Engineering under the Educational Committee on Animal Resources approved protocols for animal use.

Genome sequencing and analysis

The genomes of XQ and XQW were prepared by using a TIANamp Bacteria DNA Kit (TIANGEN). The sequencing was performed by Department of Bioinformatics (Beijing Institute of Microbiology and Epidemiology), with an Ion Torrent PGM sequenator. The acquired contigs were assembled by Roche 454 Newbler 2.5 assembler while the gaps within the unaccomplished genome were filled by GapFiller (version 1.11). The accession number for XQ was obtained (CP013137.1) after submission of the whole-genome sequence to the GenBank. Genome comparison between XQ and XQW was carried out using Mauve software.

Mutant construction

Newman is an ideal genetic manipulation S. aureus strainCitation50. The SigB(Q225P) mutation was introduced to Newman to generate Newman-SigB(Q225P) by allelic replacement strategy as describedCitation51. To further illustrate the role of SigB(Q225P) on biofilm formation, a sigB-deleted mutant (Newman-ΔSigB) was also constructed. Newman-ΔSigB/SigB and Newman-ΔSigB/SigB(Q225P) were constructed with recombinant pLI50 plasmids for complement of the wild-type SigB and SigB(Q225P), respectively. The empty pLI50 plasmid transformed Newman-ΔSigB (Newman-ΔSigB/pLI50) served as negative control.

Detection of carotenoids in S. aureus

S. aureus strains were cultured overnight at 37 °C. One milliliter of cell culture was collected and centrifuged. Cell pellets were washed thrice with sterilized water and then resuspended with 200 μL of methanol and heated for 3 min at 55 °C. After centrifuged at 10,000×g for 1 min, the supernatant was transferred to a 96-well plate, and the OD462 value was read using a Bio-Tek microplate reader. All experiments were repeated three times.

Biofilm formation and detection

Biofilm formation was performed according to previous studies with some modificationsCitation30. Briefly, the overnight bacterial culture was 1:40 diluted in TSB medium containing 1% glucose and 2% NaCl. Two hundred microliters of the cell suspension were added to a sterile 96-well plate in triplicate. After incubation 24 h at 37 °C, wells were washed thrice with sterilized water, stained with 0.1% crystal violet for 1 min, and washed again with water. After that, the crystal violet was solubilized with 30% glacial acetic acid for 15 min. The relative biofilm formation was determined by detecting the OD492 values using a Bio-Tek microplate reader.

For confocal microscopy, S. aureus strain of interest was cultured on a clean coverslip put in a sterile six-well plate (5 mL per well). After incubation 24 h at 37 °C, the coverslip was fixed with 2.5% glutaraldehyde, washed with PBS, and stained with 50 mg/L of FITC-labeled ConA (Sigma) for 30 min. After being washed with PBS again, the coverslip was blocked with propidium iodide (5 mg/L, Sigma) for 8 min and observed under a confocal laser microscope (Leica TCS-NT). The polysaccharides of biofilm were stained green and the bacterial nucleoid was stained red.

DNase I treatment assay

The overnight bacterial culture was 1:40 diluted in TSB medium containing 1% glucose, 2% NaCl, and 1 unit of DNase I, and cultured for 24 h in a 96-well plate. Wells were washed thrice with water, stained with crystal violet, and detected as described before.

Extraction and quantification of eDNA

eDNA extraction and quantification was performed according to a previous study with some modificationsCitation33. In brief, bacteria were grown in six-well plates for 24 h at 37 °C, then plates were chilled for 1 h at 4 °C, added with 1 μL of 0.5 M EDTA per well. The supernatants were discarded, and the unwashed biofilms were resuspended in 400 μL of RB buffer (50 mM Tris-HCl, 10 mM ETDA, 500 mM NaCl, pH 8.0) and transferred into precooling tubes. After centrifugation at 18,000×g for 5 min at 4 °C, 200 μL of supernatant was transferred to a new chilled tube containing 300 μL of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Proteins were removed once with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) and once with chloroform/isoamyl alcohol (24:1), DNA was then precipitated by adding three volumes of ice-cold 100% ethanol and 1/10 volume of 3 M sodium acetate to the aqueous phase. Precipitations were incubated overnight at −20 °C. The next day, the ethanol-precipitated DNA was collected by centrifugation at 18,000×g for 20 min at 4 °C, followed by washing with ice-cold 70% ethanol, air-dried, and dissolved in 20 μL of TE buffer. eDNA was quantified using NanoDrop 1000 spectrophotometer. To account for potential differences in biomass, the average OD600 values of each unwashed biofilm were determined. The nanogram of eDNA per biomass of each biofilm was then calculated via dividing its total eDNA (ng) by its corresponding OD600 value. The eDNA samples from XQ and XQW were also compared via running on 1.0% agarose gels. Experiments were repeated twice.

RT-qPCR

The overnight cultures of XQ and XQW were transferred into fresh TSB at the dilution of 1:100, respectively. Bacteria at the later growth stages (6 h after inoculation) were harvested; the total RNA and corresponding cDNA were prepared using RNAprep Pure Cell/Bacteria Kit (TIANGEN) and RevertAid First Stand cDNA Synthesis Kit (Thermo Scientific), respectively. RT-qPCR was performed to detect the toxin genes (RNAIII, seb, lukF, hla, hlg, lipA, and sspA) in S. aureus strains of interest, and the expression level of genes related to biofilm formation, including nuc, fnbA, fnbB, clfA, and icaA, were also determined using primers listed in Supplementary Table S2. The relative expression levels of tested genes were normalized to that of 16S RNA gene or gyrB.

Construction of the nuc promoter-LacZ reporter strain

The fragment spans −334 to +72 of nuc gene promoter region was amplified from S. aureus Newman using primer pairs listed in Supplementary Table S2, and the PCR product was inserted into pOS1 vector through EcoRI and BamHI digestion. The recombinant plasmid was transformed into E. coli DH5a and verified by sequencing. Correctly constructed pOS1-nuc promoter-LacZ reporter plasmid was transformed into S. aureus RN4220, and then transformed into S. aureus Newman and Newman-SigB(Q225P), respectively.

β-galactosidase assay

Both Newman and Newman-SigB(Q225P) carrying nuc promoter-LacZ reporter were cultured overnight and washed twice with PBS and diluted 100-fold in fresh TSB medium, respectively. Bacteria cells in 2 mL culture were harvested after being cultured for 3 h at 37 °C with shaking, resuspended in 100 μL of AB buffer (100 mM KH2PO4, 100 mM NaCl, pH 7.0)Citation52. After treatment with lysostaphin (1 mg/mL, Sigma) for 15 min at 37 °C, the suspension was added with another 900 μL of ABT solution (AB buffer containing 0.1% TritonX-100). Fifty microliters of the solution were then mixed with 10 μL of 4-methylumbelliferyl-β-d-galactoside (4MUG, 4 mg/mL, Sigma) and incubated for 1 h at room temperature. Then, 20 μL of the sample was mixed with 180 μL of ABT solution, and the reaction was monitored at 445 nm with an excitation wavelength of 365 nm. All samples were tested in triplicate.

EMSA

A DNA fragment derived from the promoter region of nuc gene was amplified from S. aureus Newman with primers listed in Supplementary Table S2. A DNA fragment from saeR gene coding region was also amplified and served as negative control. The PCR products were purified utilizing Wizard® SV Gel and PCR Clean-Up System (Promega). SigB, as well as SigB(Q225P) proteins, were prepared in our laboratory. In brief, sigB and sigB(Q225P) genes were cloned into a pET22b vector, respectively. Corresponding proteins with a 6× His-Tag at the C-terminal were purified via Ni-NTA column and identified by SDS-PAGE and western blot. The binding reactions of EMSA were performed in a buffer system (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 50 mM NaCl, and 5% glycerol) for 30 min at room temperature. The amount of DNA fragment was maintained at 10 pmol per reaction while the amount of proteins was increased from 0 to 18 μg. Reaction mixtures were then electrophoresed on a 5% nondenaturing polyacrylamide gel at 80 V for 2–3 h at 4 °C. Gels were stained with GoldView (Solarbio) and observed under UV light. To compare the DNA binding ability of SigB and SigB(Q225P), the gray value of free probe in each lane was analyzed using ImageJ software. The gray value of free probe in first lane (0 μg protein) was adjusted to 1.0, and the relative gray values in other lanes were calculated.

BLI assay

The BLI assay was performed to quantitatively detect the DNA binding ability of SigB and SigB(Q225P) using Octet K2 system (ForteBio). Biotin-labeled nuc promoter region was amplified by PCR using primer pairs (Biotin-labeled sigB promoter-5′ and sigB promoter-3′). PCR products were purified using the Wizard SV gel and PCR clean up system (Promega), quantified using a NanoDrop 1000 (Thermo), and loaded onto ReadTM Streptavidin (SA) biosensors (ForteBio). In a typical binding assay, SigB and BSA proteins (500 nM, dissolved in PBS, pH 7.4) were firstly used to check the specificity of the system. Then, SigB and SigB(Q225P) proteins at different concentrations (125 and 250 nM, dissolved in PBS, pH 7.4) were used to evaluate their DNA binding abilities as following: baseline step (40 s), association step (120 s), dissociation step (180 s), and regeneration step (45 s). Data were treated via Octet System Data Analysis software 8.1.

Animal experiments

BALB/c mice were injected with S. aureus strains of interest for virulence evaluation. To evaluate the lethality, mice were injected with 4 × 107 CFU of bacteria cells via tail vein (10 mice for each strain) and observed for up to 14 days. Survival was recorded and the survival curve was completed using GraphPad Prism 5 software. To detect the colonization ability of S. aureus strain of interest, mice were injected with 1 × 107 CFU of bacteria cells through tail vein (10 mice for each strain). Four days later, all mice were sacrificed and the bacterial loads in liver, kidney, and liver tissues were counted after inoculation of serially diluted organ suspensions on TSB plates and cultured for 24 h at 37 °C, respectively. For skin abscess formation, mice were first treated with 6% Na2S to remove the back hair, and then subcutaneously injected with 1 × 107 CFU of bacteria cells. Skin abscess formations were observed and recorded up to 10 days.

Statistical analysis

Statistical analysis of results was carried out using GraphPad Prism 5. Unpaired two-tailed Student’s t-test was used to treat samples between two groups. The differences between multiple groups were analyzed by one-way analysis of variance (ANOVA) with Turkey’s multiple-comparison test. Each experiment was carried out at least thrice. Results are presented as mean ± standard deviations (SD), and a P value less than 0.05 was considered statistically significant. *P< 0.05, **P< 0.01, ***P< 0.001, and ns represented no significance.

Supplemental material

Supplementary information

Download MS Word (7.7 MB)

Acknowledgements

This work was supported by National Key Biosafety Technology Research and Development Program of China (2017YFC1200404-4), National Natural Science Foundation of China (X.R., Grant no. 81672071; S.L., Grant no. 31470241). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author contributions

Y.Y., X.R., R.Z., and X.H. conceived and designed the experiments. H.L., W.S., Y.Y., Z.H., Y.Z., J.Y., H.P., X.C., and L.T. performed the experiments. Y.Y., X.R., Q.H., S.L., J.Z., and M.L. analyzed the data. Y.Y. and X.R. wrote the manuscript. All authors discussed the results and commented on the manuscript. The principal investigators were X.R. and S.L.

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Supplementary Information accompanies this paper at (10.1038/s41426-018-0078-1).

References

  • DavidMZDaumRSCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicClin. Microbiol Rev.201023 616 68710.1128/CMR.00081-092901661
  • ReddyPNSriramaKDirisalaVRAn update on clinical burden, diagnostic tools, and therapeutic options of Staphylococcus aureusInfect. Dis.2017101179916117703999
  • LiuYXuZYangZSunJMaLCharacterization of community-associated Staphylococcus aureus from skin and soft-tissue infections: a multicenter study in ChinaEmerg. Microbes Infect.2016510.1038/emi.2016.1285180372
  • LeeBYThe economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)Clin. Microbiol Infect.20131952853610.1111/j.1469-0691.2012.03914.x
  • VenkatesanNPerumalGDobleMBacterial resistance in biofilm-associated bacteriaFuture Microbiol2015101743175010.2217/fmb.15.69
  • BhattacharyaMWozniakDJStoodleyPHall-StoodleyLPrevention and treatment of Staphylococcus aureus biofilmsExpert Rev. Anti Infect. Ther.2015131499151610.1586/14787210.2015.11005335142822
  • OttoMBacterial evasion of antimicrobial peptides by biofilm formationCurr. Top. Microbiol Immunol.2006306251258
  • DonlanRMCostertonJWBiofilms: survival mechanisms of clinically relevant microorganismsClin. Microbiol Rev.20021516719310.1128/CMR.15.2.167-193.2002118068
  • CostertonJWStewartPSGreenbergEPBacterial biofilms: a common cause of persistent infectionsScience19992841318132210.1126/science.284.5418.1318
  • McConougheySJBiofilms in periprosthetic orthopedic infectionsFuture Microbiol.20149987100710.2217/fmb.14.644407677
  • Hall-StoodleyLCostertonJWStoodleyPBacterial biofilms: from the natural environment to infectious diseasesNat. Rev. Microbiol.200429510810.1038/nrmicro821
  • van SchaikWAbeeTThe role of sigmaB in the stress response of Gram-positive bacteria -- targets for food preservation and safetyCurr. Opin. Biotechnol.20051621822410.1016/j.copbio.2005.01.008
  • NicholasROIsolation and characterization of a sigB deletion mutant of Staphylococcus aureusInfect. Immun.19996736673669116562
  • MitchellGSigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variantsPLoS One20138e6501810.1371/journal.pone.00650183660380
  • TuchscherrLLöfflerBStaphylococcus aureus dynamically adapts global regulators and virulence factor expression in the course from acute to chronic infectionCurr. Genet201662151710.1007/s00294-015-0503-0
  • CheungALChienYTBayerASHyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureusInfect. Immun.1999671331133796465
  • ArciolaCRCampocciaDSpezialePMontanaroLCostertonJWBiofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materialsBiomaterials2012335967598210.1016/j.biomaterials.2012.05.031
  • ChenFSmall-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulenceNat. Chem. Biol.20161217417910.1038/nchembio.2003
  • BischoffMMicroarray-based analysis of the Staphylococcus aureus sigmaB regulonJ. Bacteriol.20041864085409910.1128/JB.186.13.4085-4099.2004421609
  • LauderdaleKJBolesBRCheungALHorswillARInterconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturationInfect. Immun.2009771623163510.1128/IAI.01036-082663138
  • KiedrowskiMRNuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureusPLoS One20116e2671410.1371/journal.pone.00267143214024
  • KnoblochJKJägerSHorstkotteMARohdeHMackDRsbU-dependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by repression of the negative regulator gene icaRInfect. Immun.2004723838384810.1128/IAI.72.7.3838-3848.2004427440
  • SavageVJChopraIO’NeillAJPopulation diversification in Staphylococcus aureus biofilms may promote dissemination and persistencePLoS ONE20138e6251310.1371/journal.pone.00625133640034
  • RaoQShangWZhouKZhouRRaoXFatal multiple organ failure in an adolescent due to community-acquired methicillin-susceptible Staphylococcus aureus ST121/agrIV lineage: case report and reviewRev. Med Microbiol20152616316710.1097/MRM.0000000000000050
  • LaneWJDarstSAThe structural basis for promoter -35 element recognition by the group IV sigma factorsPLoS Biol.20064e26910.1371/journal.pbio.00402691540707
  • LiuGYStaphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activityJ. Exp. Med.200520220921510.1084/jem.200508462213009
  • LiuCIA cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulenceScience20083191391139410.1126/science.11530182747771
  • LeKYOttoMQuorum-sensing regulation in staphylococci-an overviewFront. Microbiol.20156117410.3389/fmicb.2015.011744621875
  • GötzFStaphylococcus and biofilmsMol. Microbiol.2002431367137810.1046/j.1365-2958.2002.02827.x
  • TrotondaMPTamberSMemmiGCheungALMgrA represses biofilm formation in Staphylococcus aureusInfect. Immun.2008765645565410.1128/IAI.00735-082583562
  • O’NeillEHumphreysHO’GaraJPCarriage of both the fnbA and fnbB genes and growth at 37 degrees C promote FnBP-mediated biofilm development in meticillin-resistant Staphylococcus aureus clinical isolatesJ. Med. Microbiol.20095839940210.1099/jmm.0.005504-0
  • OlsonMEStaphylococcus aureus nuclease is an SaeRS-dependent virulence factorInfect. Immun.2013811316132410.1128/IAI.01242-123639593
  • RiceKCThecidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureusProc. Natl Acad. Sci. USA20071048113811810.1073/pnas.06102261041876580
  • Pané-FarréJJonasBFörstnerKEngelmannSHeckerMThe sigmaB regulon in Staphylococcus aureus and its regulationInt. J. Med. Microbiol.200629623725810.1016/j.ijmm.2005.11.011
  • FigueiredoAMSFerreiraFABeltrameCOCôrtesMFThe role of biofilms in persistent infections and factors involved in ica-independent biofilm development and gene regulation in Staphylococcus aureusCrit. Rev. Microbiol.20174360262010.1080/1040841X.2017.1282941
  • HoustonPRoweSEPozziCWatersEMO’GaraJPEssential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotypeInfect. Immun.2011791153116510.1128/IAI.00364-10
  • ListerJLHorswillARStaphylococcus aureus biofilms: recent developments in biofilm dispersalFront. Cell Infect. Microbiol.2014417810.3389/fcimb.2014.001784275032
  • TanXTranscriptome analysis of the biofilm formed by methicillin-susceptible Staphylococcus aureusSci. Rep.2015510.1038/srep119974493712
  • KiedrowskiMRStaphylococcus aureus Nuc2 is a functional, surface-attached extracellular nucleasePLoS ONE20149e9557410.1371/journal.pone.00955743994088
  • PeriasamySHow Staphylococcus aureus biofilms develop their characteristic structureProc. Natl Acad. Sci. USA20121091281128610.1073/pnas.11150061093268330
  • DubracSBonecaIGPoupelOMsadekTNew insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureusJ. Bacteriol.20071898257826910.1128/JB.00645-072168699
  • Sharma-KuinkelBKThe Staphylococcus aureus LytSR two-component regulatory system affects biofilm formationJ. Bacteriol.20091914767477510.1128/JB.00348-092715716
  • MashruwalaAAGriesCMScherrTDKielianTBoydJMSaeRS is responsive to cellular respiratory status and regulates fermentative biofilm formation in Staphylococcus aureusInfect. Immun.201785e0015710.1128/IAI.00157-175520442
  • MashruwalaAAGuchteAVBoydJMImpaired respiration elicits SrrAB-dependent programmed cell lysis and biofilm formation in Staphylococcus aureusElife20176e2384510.7554/eLife.238455380435
  • MootzJMRot is a key regulator of Staphylococcus aureus biofilm formationMol. Microbiol20159638840410.1111/mmi.129434467170
  • CrosbyHAThe Staphylococcus aureus global regulator MgrA modulates clumping and virulence by controlling surface protein expressionPLoS Pathog.201612e100560410.1371/journal.ppat.10056044856396
  • SchulthessBThe σB-dependent yabJ-spoVG operon is involved in the regulation of extracellular nuclease, lipase, and protease expression in Staphylococcus aureusJ. Bacteriol.20111934954496210.1128/JB.05362-113165683
  • LanLChengADunmanPMMissiakasDHeCGolden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureusJ. Bacteriol.20101923068307710.1128/JB.00928-092901709
  • AndreyDOImpact of the regulators SigB, Rot, SarA and sarS on the toxic shock Tst promoter and TSST-1 expression in Staphylococcus aureusPLoS ONE201510e013557910.1371/journal.pone.01355794537247
  • BabaTBaeTSchneewindOTakeuchiFHiramatsuKGenome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islandsJ. Bacteriol.200819030031010.1128/JB.01000-07
  • PengHWalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108J. Antimicrob. Chemother.20177210061013
  • DengXExpression of multidrug resistance efflux pump gene norA is iron responsive in Staphylococcus aureusJ. Bacteriol.20121941753176210.1128/JB.06582-113302473